Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways.
about
Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathwaysMembrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cellsXenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cellsXenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways.Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functionsThe roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells17beta-estradiol-mediated neuroprotection and ERK activation require a pertussis toxin-sensitive mechanism involving GRK2 and beta-arrestin-1Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux.Proliferative and anti-proliferative effects of dietary levels of phytoestrogens in rat pituitary GH3/B6/F10 cells - the involvement of rapidly activated kinases and caspases.Sex differences in estrogen receptor subcellular location and activity in lung adenocarcinoma cellsNongenomic signaling pathways of estrogen toxicity.NAD-dependent isocitrate dehydrogenase as a novel target of tributyltin in human embryonic carcinoma cellsClick synthesis of estradiol-cyclodextrin conjugates as cell compartment selective estrogensQuantitative changes in intracellular calcium and extracellular-regulated kinase activation measured in parallel in CHO cells stably expressing serotonin (5-HT) 5-HT2A or 5-HT2C receptors.Combinations of physiologic estrogens with xenoestrogens alter calcium and kinase responses, prolactin release, and membrane estrogen receptor trafficking in rat pituitary cells.Estrogens of multiple classes and their role in mental health disease mechanisms.Direct estradiol and diethylstilbestrol actions on early- versus late-stage prostate cancer cells.Insulin-like growth factor-I E-peptide activity is dependent on the IGF-I receptor.Combinations of physiologic estrogens with xenoestrogens alter ERK phosphorylation profiles in rat pituitary cells.Alkylphenol xenoestrogens with varying carbon chain lengths differentially and potently activate signaling and functional responses in GH3/B6/F10 somatomammotropesEstradiol effects on the dopamine transporter - protein levels, subcellular location, and function.Xenoestrogens are potent activators of nongenomic estrogenic responses.International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic ModulatorsEstrogen- and xenoestrogen-induced ERK signaling in pituitary tumor cells involves estrogen receptor-α interactions with G protein-αi and caveolin I.Controllable drug uptake and nongenomic response through estrogen-anchored cyclodextrin drug complexNongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues.Non-genomic effects of xenoestrogen mixtures.Mixtures of xenoestrogens disrupt estradiol-induced non-genomic signaling and downstream functions in pituitary cells.Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation.Synthesis and characterization of bioactive tamoxifen-conjugated polymers.Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx.Key developments in endocrine disrupter research and human health.Membrane estrogen receptor-alpha-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells.Estrogen Regulation of MicroRNA ExpressionToxicological mechanism of endocrine disrupting chemicals:is estrogen receptor involved?Molecular pathways: environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome.Rapid actions of xenoestrogens disrupt normal estrogenic signalingEstrogenic endocrine-disrupting chemicals: molecular mechanisms of actions on putative human diseases.Membrane lipid rafts and estrogenic signalling: a functional role in the modulation of cell homeostasis.MAPK and NF-κB pathways are involved in bisphenol A-induced TNF-α and IL-6 production in BV2 microglial cells.
P2860
Q24628902-23EC1F9E-6F6D-428E-A0E3-CA8B40C75ECFQ24796725-3F44D036-95BF-49C9-A208-FB631CA3E21DQ24814754-9B76B742-97ED-44F9-B2E7-E3F77E1F0228Q25255799-84C667D4-2FD4-4D4C-BFAE-4F5726E00481Q28286592-997207CD-1BE1-42C5-892F-357093331A37Q28571211-75055A6E-95AC-4CEF-AC3F-25B139DEFDFDQ28581194-A8064086-CD7C-4AE9-B4F1-713B14902B26Q33468630-CF4A6F0C-C164-4632-BDFD-F4953414F944Q33504908-F93771E6-A829-4558-B6D7-A55205B176E6Q33695898-B5FCE4E4-1DA5-407D-BB83-0A0C1BA6CA65Q33988964-0B48033A-400D-4783-A2D3-FE531243E4CEQ34001493-26BD499C-6B0F-4635-8685-7EC4DA0AC5CDQ34006085-80AE6058-BF0C-4426-95D8-B140F9A3170CQ34187552-B8EA21C8-EF8F-40A3-A47E-E371DE29C484Q34258178-BD40E5DF-3DE5-4F35-B416-7EEEF5F02D43Q34272184-C3C712B5-2216-4DA4-9C33-B49B42A29886Q34381523-F6F990F4-5658-4379-825E-86A3943F1606Q34429527-142EB3BD-2BF2-4139-B288-E1FFCE9DD258Q34478440-6DE34187-7655-4BA7-99E8-2F757F46B010Q34983692-13B321C5-C5D7-448A-9236-47DD5033B747Q35585729-39A8A6E1-D2C9-4896-984F-A1194BDF9B29Q35776394-A24C1FA0-BE0C-46C9-8E7C-8358C6303001Q35795751-0EA7F3A1-F9EA-4FCB-9E13-FB1E6F4E3BCCQ35831036-9A840716-8E3A-4155-BD59-C92058C6AACFQ35914934-84B5B587-C990-40C4-908E-DD75AE6999FAQ36003029-F0C8C499-8774-4DC7-80E0-04750167754FQ36248853-18E50702-1C24-4D95-88F7-B2EF15EA768FQ36814779-F007E1F7-3E79-4F61-913C-7EAB09E24A15Q36841766-6FF5235D-0473-418D-9B69-F2B30755077BQ36859343-D80EECCB-A1A5-4958-8469-04CC57CF91F2Q37015361-6AE065FA-EA19-4559-B9A9-ABEF78D29DBFQ37119910-E878A23C-6B7F-4F24-8496-AE4938D57088Q37185940-6344411F-13B5-4760-A186-98F2003241C0Q37250659-5B05BB62-D3C7-470C-9902-F4F7A87D8A7EQ37326623-8286BFC2-D306-4892-8B17-E004B955A93AQ37429937-CED8E4BA-66BD-4B5C-ACDE-B2F7DF505AD2Q37626901-0C718FDE-EEA0-431A-9159-F1E1A6A2D952Q38205851-75A6895D-F582-41B5-A264-4B00EE69D0FAQ38338331-A7F3C09C-3CB6-4484-8B16-02650892BA39Q38973226-24AF1798-6554-442C-8DB8-1F386BEE9795
P2860
Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Quantitative measurement of es ...... -initiated signaling pathways.
@ast
Quantitative measurement of es ...... -initiated signaling pathways.
@en
type
label
Quantitative measurement of es ...... -initiated signaling pathways.
@ast
Quantitative measurement of es ...... -initiated signaling pathways.
@en
prefLabel
Quantitative measurement of es ...... -initiated signaling pathways.
@ast
Quantitative measurement of es ...... -initiated signaling pathways.
@en
P2093
P2860
P1433
P1476
Quantitative measurement of es ...... -initiated signaling pathways.
@en
P2093
Bahiru Gametchu
Cheryl S Watson
Nataliya N Bulayeva
P2860
P304
P356
10.1016/J.STEROIDS.2003.12.003
P577
2004-03-01T00:00:00Z